Magee Thomson Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-19,050
| Closed | -$10.3M | – | 111 |
|
|
2015
Q4 | $10.3M | Buy |
19,050
+2,560
| +16% | +$1.39M | 2.85% | 19 |
|
|
2015
Q3 | $7.67M | Buy |
16,490
+2,350
| +17% | +$1.09M | 2.36% | 22 |
|
|
2015
Q2 | $7.21M | Sell |
14,140
-26,220
| -65% | -$13.4M | 2.09% | 29 |
|
|
2015
Q1 | $18.2M | Sell |
40,360
-980
| -2% | -$442K | 4.41% | 4 |
|
|
2014
Q4 | $17M | Buy |
41,340
+1,630
| +4% | +$669K | 4.22% | 5 |
|
|
2014
Q3 | $14.3M | Buy |
39,710
+1,880
| +5% | +$678K | 3.53% | 9 |
|
|
2014
Q2 | $10.7M | Sell |
37,830
-2,980
| -7% | -$842K | 2.61% | 21 |
|
|
2014
Q1 | $12.3M | Buy |
40,810
+305
| +0.8% | +$91.6K | 2.78% | 21 |
|
|
2013
Q4 | $11.1M | Sell |
40,505
-199
| -0.5% | -$54.8K | 2.47% | 25 |
|
|
2013
Q3 | $12.7M | Buy |
+40,704
| New | +$12.7M | 2.56% | 26 |
|